INVESTING IN INVESTMENT: THE LONG TERM STRATEGY FOR CGT GROWTH IN EUROPE

31 Aug 2022
11:00
SPONSORED BY
Catenion

11:00 – CHAIR INTRODUCTION

Chair: Ann-Hunter Van Kirk, Senior Equity Research Analyst Biopharmaceuticals, Bloomberg LP

 

11:05 – FIRESIDE CHAT: SOURCING & CULTIVATING FUNDING IN EUROPEAN CGT

Speakers:

Dmitrij Hristodorov, Partner, Forbion 

Alex Hamilton, Partner, Syncona

11:25 – CHAIR INTRODUCTION

Chair: Sven Kili, CEO, Antion Biosciences

 

11:30 – FIRESIDE CHAT: HARNESSING THE POWER OF ALTERNATIVE BIOTECH FUNDING SOURCES FOR EXPEDITED ACCESS TO EUROPEAN INVESTMENT  

Speakers:

Amro Eid, Director of Business Development, Freemind Group

Bryan Kobel, CEO, TC BioPharm

Pamela Tranter, Head Translational Research Group, UCL Translational Research Office

 

11:50 – CHAIR INTRODUCTION

Chair: Bryan Poltilove, Operating Partner, BroadOak Capital Partners

 

11:55 – FIRESIDE CHAT: SECURING FUNDING & COMMERCIAL STRUCTURING FOR SUCCESSFUL EARLY-STAGE BIOTECH 

Speakers:

Oliver Sexton, Investment Director, UK Innovation and Science Seed Fund

Tim Funnell, Partner, Monograph Capital

Arthur Stril, Chief Business Officer, Cellectis

12:15 – CASE STUDY: TARGET PRIORITISATION: BUILDING A BALANCED PIPELINE USING A SYSTEMATIC DATA DRIVEN APPROACH

Speaker: Pascal Joly, Principal, Catenion

Speakers

Ann-Hunter Van Kirk
Senior Equity Research Analyst Biopharmaceuticals
Bloomberg Intelligence
Sven Kili
Chief Executive Officer
Antion
Amro Eid
Director of Business Development
Pamela Tranter
Head Translational Research Group, UCL Translational Research Office
UCL
Oliver Sexton
Investment Director
UK Innovation & Science Seed Fund
Tim Funnell
Partner
Monograph Capital
Arthur Stril
Chief Business Officer
Cellectis
Owen Smith
Partner
4Bio
Bryan Poltilove
Operating Partner
BroadOak Partners
Pascal Joly
Principal
Catenion